Published in Gastroenterology on June 01, 1998
IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol (2011) 1.94
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut (2006) 1.47
Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol (2011) 1.45
T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. Gastroenterology (2014) 1.23
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 1.20
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol (2004) 1.14
Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol (2010) 1.08
Salmonella enterica serovar typhimurium invades fibroblasts by multiple routes differing from the entry into epithelial cells. Infect Immun (2010) 1.05
Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis. Cell Mol Gastroenterol Hepatol (2015) 1.00
Human intestinal epithelial and smooth muscle cells are potent producers of IL-6. Mediators Inflamm (2003) 0.94
Genome expression analysis of nonproliferating intracellular Salmonella enterica serovar Typhimurium unravels an acid pH-dependent PhoP-PhoQ response essential for dormancy. Infect Immun (2012) 0.91
Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries. J Clin Immunol (2001) 0.89
The Role of STAT1 for Crosstalk between Fibroblasts and Colon Cancer Cells. Front Oncol (2014) 0.86
Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut (1999) 0.84
The epithelial danger signal IL-1α is a potent activator of fibroblasts and reactivator of intestinal inflammation. Am J Pathol (2015) 0.83
Hyaluronan Synthase 3 Null Mice Exhibit Decreased Intestinal Inflammation and Tissue Damage in the DSS-Induced Colitis Model. Int J Cell Biol (2015) 0.83
Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn's disease-associated fibrosis. Clin Epigenetics (2016) 0.81
Small bowel review: normal physiology part 2. Dig Dis Sci (2001) 0.81
Crohn's Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments. Cell Mol Gastroenterol Hepatol (2016) 0.78
Bioluminescence imaging for IL-1β expression in experimental colitis. J Inflamm (Lond) (2013) 0.77
Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity (1999) 7.34
Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol (1999) 2.95
Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol (1995) 2.71
Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet (2001) 2.64
IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol (1999) 2.58
Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol (1999) 2.11
Review article: breath analysis in inflammatory bowel diseases. Aliment Pharmacol Ther (2014) 2.02
Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest (2001) 1.96
Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut (2001) 1.92
Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology (1993) 1.75
Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology (2001) 1.69
Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol (1997) 1.68
Cost-utility of initial medical management for Crohn's disease perianal fistulae. Gastroenterology (2001) 1.63
Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization. Dig Dis Sci (1979) 1.60
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut (2003) 1.56
Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest (1994) 1.53
Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. Gastroenterology (2001) 1.52
Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology (1997) 1.51
Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. Gastroenterology (1986) 1.50
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease. Dig Liver Dis (2001) 1.39
Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology (1999) 1.35
Intestinal immunity and inflammation: recent progress. Gastroenterology (1986) 1.32
Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology (1996) 1.31
The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology (1999) 1.31
Immunoregulatory function of lamina propria T cells in Crohn's disease. Gastroenterology (1985) 1.27
Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci (1988) 1.24
Lessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease. Am J Physiol Gastrointest Liver Physiol (2000) 1.22
A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli. Virology (2001) 1.22
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut (2007) 1.18
The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut (2004) 1.18
Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma. Dig Dis Sci (1988) 1.13
CD4 positive Leu-8 negative helper-inducer T cells predominate in the human intestinal lamina propria. J Immunol (1988) 1.11
New isolation technique to study apoptosis in human intestinal epithelial cells. Am J Pathol (1998) 1.10
Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am J Physiol (1998) 1.10
Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. Gastroenterology (1985) 1.08
Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology (1991) 1.07
Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. Gut (1993) 1.07
Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet (1998) 1.06
Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther (1996) 1.05
Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterology (1989) 1.05
Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut (2004) 1.04
Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol (1994) 1.03
Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides. Dig Dis Sci (1981) 1.03
Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut (2007) 1.01
Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis. Genes Immun (2011) 1.01
High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol (1999) 1.00
Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun (1999) 0.98
A 'minimal' approach in design of flavivirus infectious DNA. Virus Res (2001) 0.98
Pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol (1999) 0.95
Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists. J Cell Physiol (1999) 0.95
Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. Gastroenterology (1992) 0.94
Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors. Gastroenterology (1988) 0.92
Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro. J Clin Invest (1985) 0.92
Bilateral pleural masses and shortness of breath associated with multiple myeloma. Chest (1997) 0.91
RadNotes: a novel software development tool for radiology education. Radiographics (1997) 0.91
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls. Neurogastroenterol Motil (2012) 0.91
Regulation of life and death in lamina propria T cells. Semin Immunol (2001) 0.89
Immune activation genes in inflammatory bowel disease. Gastroenterology (1993) 0.89
Regulation of ICAM-1-mediated fibroblast-T cell reciprocal interaction: implications for modulation of gut inflammation. Gastroenterology (1999) 0.89
Hypoproliferative human lamina propria T cells retain the capacity to secrete lymphokines when stimulated via CD2/CD28 pathways. Proc Assoc Am Physicians (1996) 0.88
Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol (1985) (1991) 0.87
Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease. Mucosal Immunol (2012) 0.87
Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology (1992) 0.86
Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial. Aliment Pharmacol Ther (1995) 0.86
Rabbit interleukin-1 receptor antagonist. Cloning, expression, functional characterization, and regulation during intestinal inflammation. J Biol Chem (1994) 0.86
The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis (2001) 0.86
A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc (1995) 0.86
Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients. J Antimicrob Chemother (2000) 0.85
Altered renal and platelet arachidonic acid metabolism in cirrhosis. Gastroenterology (1986) 0.85
Calcitonin gene-related peptide and substance P decrease in the rabbit colon during colitis. A time study. Gastroenterology (1991) 0.84
Pulmonary infarction resulting from metastatic osteogenic sarcoma with pulmonary venous tumor thrombus. AJR Am J Roentgenol (2000) 0.84
Allergy skin testing. Mayo Clin Proc (1995) 0.84
Effects of 16,16-dimethyl prostaglandin E2 and indomethacin on leukotriene B4 and inflammation in rabbit colitis. Prostaglandins (1988) 0.83
Potent inhibition of gastric acid secretion by intravenous interleukin-1 beta and -1 alpha in rats. Peptides (1992) 0.83
Radiographic distribution of Pneumocystis carinii pneumonia in patients with AIDS treated with prophylactic inhaled pentamidine. Radiology (1990) 0.83
Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease. J Pediatr (1998) 0.83
Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites. Gastroenterology (1988) 0.83
Recombinant interleukin 10 for the treatment of active Crohn's disease: lessons in biologic therapy. Gastroenterology (2000) 0.82
Biochemical properties, activities, and presence in biologic fluids of eosinophil granule major basic protein. J Allergy Clin Immunol (1994) 0.82
Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies? Gut (2006) 0.82
Immunology of inflammatory bowel disease. Curr Opin Gastroenterol (2000) 0.81
From immune activation to gut tissue injury: the pieces of the puzzle are coming together. Gastroenterology (1999) 0.81
Effects of oral prostaglandins on indomethacin-induced renal failure in patients with cirrhosis and ascites. J Rheumatol Suppl (1990) 0.81